Retinoic Acid Combined with Neurotrophin-3 Enhances the Survival and Neurite Outgrowth of Embryonic Sympathetic Neurons
Overview
Authors
Affiliations
Both nerve growth factor (NGF) and neurotrophin-3 (NT-3) are necessary for the survival of embryonic sympathetic neurons in vivo. All-trans retinoic acid (atRA) has been shown to promote neurite outgrowth and long-term survival of chick embryonic sympathetic neurons cultured in the presence of NGF. The present study shows that atRA can also potentiate the survival and neurite outgrowth-promoting activities of NT-3. This was accomplished by enhancing the survival of existing neurons, as cell proliferation was unaffected by exposure to atRA. atRA also enhanced neurite outgrowth of the NT-3-treated cells; however, the neurites appeared thicker and less branched than cells treated with atRA in combination with NGF. Using a quantitative PCR assay, trkA and p75(NTR) mRNAs, but not trkC mRNA, were increased ( approximately 1.5- to 2-fold) after 72 and 48 hr of exposure of the cultures to atRA, respectively. The atRA-induced increase in trkA mRNA may play a role in the enhanced survival of neurons cultured in the presence of either NGF or NT-3, as both neurotrophins have been shown to signal through this receptor. The time course of these mRNA changes would indicate that atRA does not regulate the neurotrophin receptor mRNA directly, rather, intervening gene transcription is required. Thus, during development, atRA may play a role in fine-tuning embryonic responsiveness to both NT-3 and NGF.
Conserva M, Anelli L, Zagaria A, Specchia G, Albano F Int J Mol Sci. 2019; 20(12).
PMID: 31207999 PMC: 6627493. DOI: 10.3390/ijms20122921.
Khatib T, Marini P, Nunna S, Chisholm D, Whiting A, Redfern C Cell Commun Signal. 2019; 17(1):40.
PMID: 31046795 PMC: 6498645. DOI: 10.1186/s12964-019-0352-4.
Bouilloux F, Thireau J, Venteo S, Farah C, Karam S, Dauvilliers Y Elife. 2016; 5.
PMID: 26857994 PMC: 4760953. DOI: 10.7554/eLife.11627.
Curcumin restores sensitivity to retinoic acid in triple negative breast cancer cells.
Thulasiraman P, McAndrews D, Mohiudddin I BMC Cancer. 2014; 14:724.
PMID: 25260874 PMC: 4192446. DOI: 10.1186/1471-2407-14-724.
Retinoids: novel immunomodulators and tumour-suppressive agents?.
Carratu M, Marasco C, Mangialardi G, Vacca A Br J Pharmacol. 2012; 167(3):483-92.
PMID: 22577845 PMC: 3449254. DOI: 10.1111/j.1476-5381.2012.02031.x.